HIV-1 GP120-DEPENDENT INDUCTION OF APOPTOSIS IN ANTIGEN-SPECIFIC HUMAN T-CELL CLONES IS CHARACTERIZED BY TISSUE TRANSGLUTAMINASE EXPRESSION AND PREVENTED BY CYCLOSPORINE-A

被引:38
|
作者
AMENDOLA, A
LOMBARDI, G
OLIVERIO, S
COLIZZI, V
PIACENTINI, M
机构
[1] UNIV ROMA TOR VERGATA, DEPT BIOL, I-00133 ROME, ITALY
[2] UNIV ROMA LA SAPIENZA, DEPT CELL BIOL & DEV, ROME, ITALY
关键词
AIDS; PROTEIN CROSS-LINKING; IMMUNE SUPPRESIVE AGENT;
D O I
10.1016/0014-5793(94)80427-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We investigated the effect of cyclosporin (CsA) on HIV-gp120-dependent induction of cell death by apoptosis of human T cell clones specific for influenza virus haemagglutinin and restricted by HLA-DR1. Preincubation of the clones with gp120 induced a large inhibition of their proliferation which was paralleled by the induction of apoptosis. Exposure to the specific antigen alone was able to trigger apoptosis in a significant fraction of cells, this effect was potentiated by pretreatment with gp120. Apoptosis was characterized by the typical morphological changes and by the expression of 'tissue' Transglutaminase (tTG), one of the few characterized effector elements of programmed cell death. Interestingly. the tTG protein induction was detectable within the first 24 hours following the gp120 treatment and preceded the appearance of the typical apoptotic phenotype. Noteworthy, CsA treatment prevented the gp120-dependent induction of apoptosis by blocking the activation of the Ca2+-dependent effector elements such as tTG.
引用
收藏
页码:258 / 264
页数:7
相关论文
共 45 条
  • [21] STABLE EXPRESSION OF THE TRANSFECTED HIV-1 ENV GENE IN A HUMAN B-CELL LINE - CHARACTERIZATION OF GP120-EXPRESSING CLONES AND IMMUNOBIOLOGICAL STUDIES
    AHMAD, A
    LADHA, A
    COHEN, EA
    MENEZES, J
    [J]. VIROLOGY, 1993, 192 (02) : 447 - 457
  • [22] FUSION OF HUMAN B-CELL LINES WITH HIV-1 ENVELOPE-EXPRESSING T-CELLS IS ENHANCED BY ANTIGEN-SPECIFIC IG RECEPTORS - POSSIBLE MECHANISM FOR ELIMINATION OF GP120-SPECIFIC B-CELLS INVIVO
    GOLDING, H
    DIMITROV, DS
    BLACKBURN, R
    MANISCHEWITZ, J
    BLUMENTHAL, R
    GOLDING, B
    [J]. JOURNAL OF IMMUNOLOGY, 1993, 150 (06): : 2506 - 2516
  • [23] Unusual presentation of acute cytomegalovirus disease during primary HIV-1 infection: antigen-specific T-cell response analyses and clinical outcome
    Capetti, Amedeo
    Piconi, Stefania
    Magni, Carlo
    Quirino, Tiziana
    Trabattoni, Daria
    Clerici, Mario
    [J]. AIDS, 2006, 20 (11) : 1566 - 1567
  • [24] ESTABLISHMENT OF T-HELPER TYPE-1-LIKE AND T-HELPER TYPE-2-LIKE HUMAN TOXAPLASMA ANTIGEN-SPECIFIC T-CELL CLONES
    DAUBENER, W
    MACKENZIE, C
    HADDING, U
    [J]. IMMUNOLOGY, 1995, 86 (01) : 79 - 84
  • [25] Expression of HIV-1 pathogenesis factor NEF in CD4 T cells impairs antigen-specific B-cell function
    Kaw, Sheetal
    Ananth, Swetha
    Tsopoulidis, Nikolaos
    Morath, Katharina
    Coban, Bahar M.
    Hohenberger, Ralph
    Bulut, Olcay C.
    Klein, Florian
    Stolp, Bettina
    Fackler, Oliver T.
    [J]. EMBO JOURNAL, 2020,
  • [26] The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral Therapy
    Gay, Cynthia L.
    Hanley, Patrick J.
    Falcinelli, Shane D.
    Kuruc, JoAnn D.
    Pedersen, Susan M.
    Kirchherr, Jennifer
    Raines, Samuel L. M.
    Motta, Cecilia M.
    Lazarski, Chris
    Chansky, Pamela
    Tanna, Jay
    Shibli, Abeer
    Datar, Anushree
    McCann, Chase D.
    Sili, Uluhan
    Ke, Ruian
    Eron, Joseph J.
    Archin, Nancie
    Goonetilleke, Nilu
    Bollard, Catherine M.
    Margolis, David M.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2024, 229 (03): : 743 - 752
  • [27] Priming of human CD4(+) antigen-specific T cells to undergo apoptosis by HIV-infected monocytes - A two-step mechanism involving the gp120 molecule
    Cottrez, F
    Manca, F
    Dalgleish, AG
    ArenzanaSeisdedos, F
    Capron, A
    Groux, H
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (02): : 257 - 266
  • [28] Induction of Strong HIV-1-Specific CD4+ T-Cell Responses Using an HIV-1 gp120/NefTat Vaccine Adjuvanted With AS02A in Antiretroviral-Treated HIV-1-Infected Individuals
    Lichterfeld, Mathias
    Gandhi, Rajesh T.
    Simmons, Rachel P.
    Flynn, Theresa
    Sbrolla, Amy
    Yu, Xu G.
    Basgoz, Nesli
    Mui, Stanley
    Williams, Katie
    Streeck, Hendrik
    Burgett-Yandow, Nicole
    Roy, Gilbert
    Janssens, Michel
    Pedneault, Louise
    Vandepapeliere, Pierre
    Koutsoukos, Marguerite
    Demoitie, Marie-Ange
    Bourguignon, Patricia
    McNally, Lisa
    Voss, Gerald
    Altfeld, Marcus
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 59 (01) : 1 - 9
  • [29] Therapeutic Vaccination Using HIV-1 gp120/NefTat/AS02A Enhances Responsiveness of NK Cells Through the Induction of gp120-Specific CD4+T Cell Help
    Jost, S.
    Rands, K.
    Lichterfeld, M.
    Gandhi, R. T.
    Altfeld, M.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A97 - A97
  • [30] Conformational instability governed by disulfide bonds partitions the dominant from subdominant helper T-cell responses specific for HIV-1 envelope glycoprotein gp120
    Nguyen, Hong-Nam P.
    Steede, N. Kalaya
    Robinson, James E.
    Landry, Samuel J.
    [J]. VACCINE, 2015, 33 (25) : 2887 - 2896